4Ishikawa M, Yogita S, Miyake H, et al. Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma.Hepatogastroenterology, 2002, 49: 1625-1631.
5Schepis F, Camma C, Niceforo D, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology, 2001, 33: 333-338.
6Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut, 2003,52: 134-139.
7Robert A, Chazouilleres O. Prothrombin time in liver failure: time,ratio, activity percentage, or international normalized ratio? Hepatology, 1996, 24: 1392-1394.
8Cui R, Wang B, Ding H, et al. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma. Chin Med J (Engl), 2002, 115: 42-45.
9Naraki T, Kohno N, Saito H, et al. gamma-Carboxyglutamic acid content of hepatocellular carcinoma-associated des-gamma-carboxy prothrombin. Biochim Biophys Acta, 2002, 1586: 287-298.
10Izumi S, Langley PG, Wendon J, et al. Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure. Hepatology,1996, 23: 1507-1511.
7Tao Han,Ying Liu,Huan Liu,Zheng-Yan Zhu,Yan Li,Shi-Xiang Xiao,Zhen Guo,Zhen-Gang Zhao,Department of Hepatology,Tianjin Institute of Hepatobiliary Disease,Tianjin Key Laboratory of Artificial Cells,Tianjin Third Central Hospital,Tianjin Medical University,83 Jintang Road,Tianjin 300170, China.Serum thymosin β4 levels in patients with hepatitis B virus-related liver failure[J].World Journal of Gastroenterology,2010,16(5):625-630. 被引量：20
